Provided are Haemophilus influenzae antigenic polypeptides having specified sequences, or variants with at least 75% sequence identity. The peptides are useful in medicaments to prevent or alleviate H. influenzae infections.
申请公布号
NZ562381(A)
申请公布日期
2011.06.30
申请号
NZ20060562381
申请日期
2006.03.30
申请人
NOVARTIS VACCINES AND DIAGNOSTICS, INC;J. CRAIG VENTER INSTITUTE, INC.
